study of Vachadi Vati and Haridradi Vati in Obesity.

An open labelled randomized comparative clinical study to evaluate the efficacy of Vachadi Vati and Haridradi Vati in Sthaulya.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/11/038258

Enrollment

Registered

2021-11-25

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E660- Obesity due to excess calories

Interventions

Intervention1: Vachadi Vati: 500 mg 2 tabs three times a day with anupan koshna jal 2 months Control Intervention1: Haridradi vati: 500 mg 2 tabs three times a day with anupan koshna jal 2 months

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients from age group of 21 to 60 years irrespective of gender, religion, socio-economic status, marital status. 2) Patients of Sthaulya i.e.as per signs and symptoms BMI >25 to 40. including overweight Obese Class I,II,III (shown in table 1) an as per signs and symptoms mentioned in Ayurvedic texts. 3) BMI >25 4) Waist To hip Ratio more than 1.0

Exclusion criteria

Exclusion criteria: 1) Pregnant women. 2) Acute life threatening conditions like C.V.A., Acute M.I. 3) B.M.I. > 40. 4) Known Cases of Hypothyroidism.

Design outcomes

Primary

Measure	Time frame
To compare the efficacy of Vachadi Vati and Haridradi Vati in Sthaulya. Timepoint: 8 weeks	—

Secondary

Measure	Time frame
To observe the adverse effect of of Vachadi Vati and Haridradi Vati in Sthaulya.Timepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Rohit shivajirao Patil

Maharashtra Aarogya Mandal Sumatibhai Shah Ayurved Mahavidyalaya

drsachinkumarpatil@yahoo.com9822603608

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026